NON CONTROLLING INTEREST (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Net loss attributable to the non-controlling interest | $ (10,357) | $ (687) |
BioCorRx Pharmaceuticals, Inc [Member] | ||
Net loss | $ (42,784) | $ (1,549) |
Average Non-controlling interest percentage of profit/losses | 24.20% | 24.20% |
Net loss attributable to the non-controlling interest | $ (10,354) | $ (375) |
Joseph DeSanto MD [Member] | ||
Net loss | $ (10) | $ (892) |
Average Non-controlling interest percentage of profit/losses | 35.00% | 35.00% |
Net loss attributable to the non-controlling interest | $ (3) | $ (312) |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|